Ilseong Sitagliptin Tablet 100 mg (Sitagliptin Phosphate)
Sitagliptin Phosphate 124.08mg
Tablet · Prescription medication
Ilseong IS Co., Ltd.
MFDS item code 201503330 · Approved 2015.05.29
This product's status changed to Expired on 2025.05.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to help control blood sugar in patients with type 2 diabetes. It serves as an adjunct to dietary and exercise therapy and can be used as monotherapy initially. If there has been no prior experience with other diabetes medications and blood sugar control is difficult with monotherapy, it can be administered in combination with metformin. Additionally, if adequate blood sugar control cannot be achieved with sulfonylureas, metformin, thiazolidinediones, or insulin monotherapy, this medication can be used in combination. If blood sugar control is still difficult with combination therapy, this medication can be used in combination with several drugs to improve blood sugar control. Overall, this medication is used to enhance blood sugar control in various situations.
This medicine is administered at a dose of 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia. Because dosage adjustment according to renal function is required, assessment of renal function before and periodically after administration of this medicine is recommended. No dosage adjustment is necessary in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60mL/min/1.73 m2 and < 90 mL/min/1.73 m2). No dosage adjustment is necessary in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45mL/min/1.73 m2 and < 60mL/min/1.73 m2). Administer 50 mg once daily in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30mL/min/1.73 m2 and < 45mL/min/1.73 m2). Administer 25 mg once daily in patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15mL/min/1.73 m2 and < 30mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.
This medication may cause severe allergic reactions, so if symptoms such as rash or difficulty breathing occur, discontinue use immediately and consult a doctor. While taking this medication, inflammation of the pancreas, known as pancreatitis, may occur, so it is essential to inform healthcare personnel if symptoms such as abdominal pain, nausea, or vomiting arise. Patients with type 1 diabetes or diabetic ketoacidosis should not use this medication, and individuals with severe allergies to the medication or its components should avoid its use. In cases of poor kidney function, dosage adjustment of this medication is required, so patients with kidney diseases must consult a doctor. This medication can be used alone or in combination with other diabetes treatments, but special care should be taken to recognize hypoglycemic symptoms, especially when used with drugs that can cause hypoglycemia, such as insulin or sulfonylureas. In clinical trials, side effects such as headaches, upper respiratory infections, rhinitis, and diarrhea have been reported; thus, if these symptoms persist or worsen, inform a doctor. This medication is not recommended for pregnant women, and nursing mothers should also avoid its use. Elderly patients may have reduced kidney function, so regular kidney function assessments are necessary before and after the use of this medication. In cases of overdose, appropriate treatments such as gastrointestinal decontamination and ECG monitoring should be provided, and it may be partially removed by hemodialysis. If symptoms such as joint pain or skin blisters occur during the use of this medication, consult a doctor immediately, as these symptoms may improve with discontinuation of the drug. Drug interactions are relatively few, but take care when used in conjunction with cyclosporine or digoxin, so inform your doctor of any medications you are taking.
Anaphylaxis, angioedema, Stevens-Johnson syndrome, exfoliative skin disease, acute pancreatitis, hypoglycemia, nasopharyngitis, upper respiratory tract infection, headache, diarrhea, abdominal pain, nausea, peripheral edema, constipation, vomiting, severe pain in joints accompanied by disability, vesiculobullous dermatitis, myalgia, limb pain, back pain, interstitial lung disease, pruritus, thrombocytopenia, rhabdomyolysis, elevated liver enzymes, acute renal failure, pneumonia, diabetes complications, metabolic acidosis, falls, cardiac arrest, dyspepsia, dizziness, increased serum triglycerides, gastritis, weight loss, hypertension, hypernatremia, erectile dysfunction
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent the ingress of air or moisture. It is advisable to store it at room temperature, between 1 degree and 30 degrees Celsius. This helps maintain the medication's efficacy and prevent degradation.
Beige-colored, double convex, round, film-coated tablet
30 tablets/box [(10 tablets/PTP x 3 pieces)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Sitagliptin Phosphate 124.08mg
Tablet · Prescription medication
Ilseong IS Co., Ltd.

Sitagliptin Phosphate Hydrate 64.25mg
Tablet · Prescription medication
Jongkeundang Co., Ltd.

Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Sitagliptin Phosphate Hydrate 32.13mg
Tablet · Prescription medication
Jong Kundang Co., Ltd.
Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication
Vivozon Pharmaceutical Co., Ltd.
Sitagliptin Phosphate Hydrate 64.25mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Sitagliptin Phosphate Hydrate 32.125mg
Tablet · Prescription medication
Sinpoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.